Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$230M |
| 2 |
Johnson & Johnson
JNJ
|
+$205M |
| 3 |
Bank of America
BAC
|
+$163M |
| 4 |
Costco
COST
|
+$162M |
| 5 |
GSK
GSK
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$396M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Walt Disney
DIS
|
+$154M |
| 5 |
Amazon
AMZN
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.2% |
| 2 | Healthcare | 13.65% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Consumer Staples | 11.26% |
| 5 | Industrials | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UBP
2326
DELISTED
Urstadt Biddle Properties Inc.
UBP
| $547K | ﹤0.01% |
34,500
-2,500
| -7% | -$40.8K |
|
|
DXYN
2327
DELISTED
Dixie Group Inc
DXYN
| $546K | ﹤0.01% |
41,400
-34,900
| -46% | -$410K |
|
|
EXAC
2328
DELISTED
Exactech Inc
EXAC
| $546K | ﹤0.01% |
23,000
-1,200
| -5% | -$27.4K |
|
|
CTIC
2329
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $546K | ﹤0.01% |
+28,575
| New | +$520K |
|
|
EDN
2330
Edenor
EDN
$994M
| $545K | ﹤0.01% |
107,700
+40,200
| +60% | +$243K |
|
|
NPTN
2331
DELISTED
NEOPHOTONICS CORP
NPTN
| $545K | ﹤0.01% |
77,200
-4,900
| -6% | -$32.7K |
|
|
SNBC
2332
DELISTED
Sun Bancorp Inc
SNBC
| $545K | ﹤0.01% |
30,940
+6,560
| +27% | +$115K |
|
2333
Ennis
EBF
$556M
| $542K | ﹤0.01% |
+30,600
| New | +$546K |
|
|
AIOT
2334
PowerFleet Inc
AIOT
$421M
| $536K | ﹤0.01% |
92,615
-19,850
| -18% | -$114K |
|
2335
Radcom
RDCM
$170M
| $535K | ﹤0.01% |
101,025
-9,100
| -8% | -$43.7K |
|
|
EGAS
2336
DELISTED
Gas Natural Inc.
EGAS
| $535K | ﹤0.01% |
66,600
+6,800
| +11% | +$63.5K |
|
|
NSTG
2337
DELISTED
NanoString Technologies, Inc.
NSTG
| $533K | ﹤0.01% |
+30,928
| New | +$383K |
|
2338
Luxfer Holdings
LXFR
$457M
| $532K | ﹤0.01% |
+25,500
| New | +$473K |
|
|
CREG
2339
DELISTED
Smart Powerr
CREG
| $531K | ﹤0.01% |
15
+2
| +15% | +$66.3K |
|
|
NBBC
2340
DELISTED
NEWBRIDGE BANCORP CLASS A COM STK (NC)
NBBC
| $531K | ﹤0.01% |
71,501
+12,301
| +21% | +$88.8K |
|
2341
NWPX Infrastructure Inc
NWPX
$1.1B
| $526K | ﹤0.01% |
13,931
+7,831
| +128% | +$285K |
|
2342
Gentherm
THRM
$1.27B
| $523K | ﹤0.01% |
+19,500
| New | +$447K |
|
2343
Casey's General Stores
CASY
$31B
| $520K | ﹤0.01% |
+7,400
| New | +$542K |
|
2344
STAAR Surgical
STAA
$1.26B
| $520K | ﹤0.01% |
32,100
-51,772
| -62% | -$692K |
|
|
DBLE
2345
DELISTED
DOUBLE EAGLE PETROLEUM CO
DBLE
| $520K | ﹤0.01% |
226,065
+46,265
| +26% | +$118K |
|
|
WMGI
2346
DELISTED
Wright Medical Group Inc
WMGI
| $514K | ﹤0.01% |
16,731
| – | – |
|
|
PDS
2347
Precision Drilling
PDS
$1.06B
| $510K | ﹤0.01% |
+2,725
| New | +$535K |
|
|
CAS
2348
DELISTED
A M Castle & Co
CAS
| $505K | ﹤0.01% |
+34,163
| New | +$497K |
|
2349
Consolidated Water Co
CWCO
$505M
| $503K | ﹤0.01% |
35,700
-43,600
| -55% | -$615K |
|
2350
Mitek Systems
MITK
$853M
| $503K | ﹤0.01% |
+84,676
| New | +$490K |
|
Similar funds
Jim Simons's Q4 2013 Portfolio in Review
As of Q4 2013, Jim Simons held 3,281 positions worth $41.8B, up 1.3% from $41.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons withdrew a net $2.31B in Q4 2013, closing 464 positions and reducing 983 holdings. Its most notable exit was GE Aerospace, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Pfizer worth $230M.
- Jim Simons's largest Q4 2013 buy was Pfizer: 7,904,832 shares worth $230M.
- Jim Simons added most to Johnson & Johnson in Q4 2013, an estimated $205M increase.
- Jim Simons's biggest Q4 2013 reduction was IBM, cutting an estimated $396M.
- Jim Simons fully exited GE Aerospace in Q4 2013, selling an estimated $156M.
- Jim Simons's ten largest holdings make up 11% of its $41.8B portfolio in Q4 2013.
- Jim Simons opened 498 new positions and closed 464 in Q4 2013.
- Jim Simons's portfolio value rose 1.3% quarter-over-quarter to $41.8B.
Based on Renaissance Technologies's 13F filing for Q4 2013, filed 14 Feb 2014.